Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

SELL
$34.32 - $57.55 $29,961 - $50,241
-873 Reduced 10.72%
7,270 $406,000
Q3 2023

Oct 24, 2023

SELL
$40.86 - $62.98 $112,773 - $173,824
-2,760 Reduced 25.31%
8,143 $335,000
Q2 2023

Jul 25, 2023

BUY
$50.96 - $58.72 $555,616 - $640,224
10,903 New
10,903 $608,000
Q4 2022

Feb 08, 2023

SELL
$24.4 - $41.3 $256,956 - $434,930
-10,531 Reduced 23.07%
35,123 $1.28 Million
Q3 2022

Oct 25, 2022

SELL
$28.48 - $52.59 $146,700 - $270,891
-5,151 Reduced 10.14%
45,654 $1.3 Million
Q2 2022

Aug 12, 2022

SELL
$36.95 - $82.41 $81,437 - $181,631
-2,204 Reduced 4.16%
50,805 $2.3 Million
Q1 2022

May 11, 2022

BUY
$55.7 - $145.79 $477,349 - $1.25 Million
8,570 Added 19.28%
53,009 $4.03 Million
Q4 2021

Feb 08, 2022

BUY
$135.05 - $182.59 $5.13 Million - $6.94 Million
37,999 Added 590.05%
44,439 $6.62 Million
Q3 2021

Nov 02, 2021

SELL
$145.58 - $192.14 $418,396 - $552,210
-2,874 Reduced 30.86%
6,440 $938,000
Q2 2021

Aug 11, 2021

SELL
$134.22 - $202.37 $1.69 Million - $2.55 Million
-12,593 Reduced 57.48%
9,314 $1.82 Million
Q1 2021

May 14, 2021

SELL
$140.25 - $196.86 $298,592 - $419,114
-2,129 Reduced 8.86%
21,907 $3.97 Million
Q4 2020

Feb 12, 2021

BUY
$126.47 - $163.7 $2.31 Million - $2.99 Million
18,254 Added 315.7%
24,036 $3.4 Million
Q3 2020

Nov 04, 2020

BUY
$87.44 - $125.0 $287,152 - $410,500
3,284 Added 131.47%
5,782 $721,000
Q2 2020

Jul 28, 2020

SELL
$58.39 - $89.31 $673,470 - $1.03 Million
-11,534 Reduced 82.2%
2,498 $223,000
Q1 2020

Apr 21, 2020

BUY
$51.57 - $106.62 $723,630 - $1.5 Million
14,032 New
14,032 $874,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.